Additional file 2: of MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

Authors :: Uccelli, Antonio
Laroni, Alice
Brundin, Lou
Clanet, Michel
Fernandez, Oscar
Nabavi, Seyed
Muraro, Paolo
Oliveri, Roberto
Radue, Ernst
Sellner, Johann
Sorensen, Per Soelberg
Sormani, Maria
Wuerfel, Jens
Battaglia, Mario
Freedman, Mark
Publication Year :: 2019
Publisher :: figshare, 2019.
Abstract: Supplementary materials. (DOCX 27 kb)

Full Text Access

Tools